These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 856918)

  • 1. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
    Levine MM; Hughes TP; Young CR; O'Donnell S; Craig JP; Holley HP; Bergquist EJ
    Infect Immun; 1978 Jul; 21(1):158-62. PubMed ID: 101456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a purified antigenic cholera toxoid.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    Infect Immun; 1976 Jun; 13(6):1692-8. PubMed ID: 823107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxoid boosts serum Escherichia coli antitoxin in humans.
    Nalin DR; al-Mahmud A; Curlin G; Ahmed A; Peterson J
    Infect Immun; 1974 Oct; 10(4):747-9. PubMed ID: 4609909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR.
    Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II
    Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.
    Pierce NF; Cray WC; Sircar BK
    Infect Immun; 1978 Jul; 21(1):185-93. PubMed ID: 711314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid.
    Pierce NF
    Ciba Found Symp; 1976; (42):129-47. PubMed ID: 1086763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response of the intestinal mucosa to cholera toxoid.
    Pierce NF; Sack RB
    J Infect Dis; 1977 Aug; 136 Suppl():S113-7. PubMed ID: 894085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A toxoid prepared from cholera toxin by iodination.
    Heneine IF; Lahmann WM; Rocha OA
    Braz J Med Biol Res; 1992; 25(9):913-7. PubMed ID: 1342838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines].
    Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.